1 September 2024

Change of Company Secretary (ASX Announcement)

Melbourne, Australia; 28 August 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) today announces, in accordance with ASX Listing Rule 3.16.1, that Tracy Weimar has resigned as Company Secretary, a role that was conducted for an interim period.

Mr Justin Cahill, Starpharma’s Chief Financial Officer and Company Secretary, continues as the person responsible for communication with ASX under ASX Listing Rule 12.6.

View or download the ASX Announcement here.

 

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.